Accu-Tell® Multi-(Line) Drug Cassette (Powder). Designed specifically for powder samples and surface residue analysis, this rapid testing kit delivers efficiency, precision, and ease of use, providing law enforcement agencies, customs, security checkpoints, and other critical scenarios with a transformative solution for narcotics screening, advancing global anti-drug efforts.
AccuBioTech Co., Ltd., a global provider of rapid in vitro diagnostic testing solutions, recently launched an innovative drug testing product, the prosthetic orthosis. Designed specifically for powder samples and surface residue analysis, this rapid testing kit delivers efficiency, precision, and ease of use, providing law enforcement agencies, customs, security checkpoints, and other critical scenarios with a transformative solution for narcotics screening, advancing global anti-drug efforts.
The Accu-Tell® Powder Drug Test is built on an immunochromatographic technology platform, utilizing monoclonal antibody-specific recognition principles to enable simultaneous qualitative detection of multiple drug components in powders. Key advantages include:
Broad Detection Spectrum: Detects up to 7 drug types in a single test, covering common and emerging narcotics such as Xylazine (XYL), Fentanyl (FYL), Carfentanyl (CFYL), Ketamine (KET), and more. Customizable test panels are available to address evolving challenges.
Exceptional Sensitivity: Detection thresholds as low as 15–5,000 ng/mL (e.g., THC detection at 15 ng/mL), ensuring precise identification of trace drug residues in powder samples.
Rapid, simple and easy to use: Requires no specialized equipment. The process involves three simple steps: swab sampling → add buffer → slide for results. Negative results are confirmed if both Control (C) and Test (T) lines appear clearly; presumptive positive results are read within 5 minutes.
With over 20 years of expertise in the IVD field, AccuBioTech remains committed to its mission of “helping people live healthier lives” by integrating cutting-edge immunochromatographic technology with real-world operational needs. The new product employs a competitive binding immunoassay mechanism, leveraging the specific binding reaction between drugs and antibodies to achieve rapid screening of powder samples. Validated to deliver >99% accuracy within ±50% of detection thresholds and exhibiting minimal cross-reactivity with structural analogs, it ensures highly reliable results.
The Accu-Tell® Multi-(Line) Drug Cassette (Powder) is adaptable to multiple scenarios, including:
Law enforcement field investigations
Customs anti-narcotics operations
Public venue security inspections
Laboratory preliminary screening
It enables rapid detection of narcotics in suspicious powders, pharmaceuticals, cosmetics, and other solid substances.
Guided by its core values of “Responsibility, Teamwork, Innovation, and Continuous Improvement,” AccuBioTech is collaborating closely with global distributors to deploy this product across more countries and regions. By harnessing technological advancements, the company aims to fortify public safety defenses and contribute to building a drug-free society.